PerkinElmer Completes Acquisition of Oxford Immunotec
PerkinElmer, Inc. today announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC. PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021. Prahlad Singh, President and CEO at PerkinElmer said, “Oxford Immunotec’s global role in fighting tuberculosis, particularly its trademark product, the T-SPOT®.TB test, and the operations it […]